Skip to content

The effect of genetic polymorphism on postoperative nausea and vomiting in obese patients undergoing laparoscopic bariatric surgery

The effect of genetic polymorphism on postoperative nausea and vomiting in obese patients undergoing laparoscopic bariatric surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092767
Enrollment
Unknown
Registered
2024-11-22
Start date
2024-12-03
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posteroperative nause and vomiting

Interventions

PONV group:NA
No PONV group:NA

Sponsors

Beijing Friendship Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.The subjects agreed to accept oral swab collection, fully understood the purpose and significance of this trial, signed the informed consent form voluntarily, and voluntarily complied with the trial process; 2.Elective laparoscopic bariatric surgery under general anesthesia; 3. Age 18-60 years old; 4. BMI>=30kg/m^2; 5. American Society of Anesthesiologists (ASA) grade I-III; 6.Subjects voluntarily used patient-controlled intravenous analgesia (PCIA) for 24-48 hours with sufentanil after extubation.

Exclusion criteria

Exclusion criteria: 1. Complicated with important organ diseases or serious systemic diseases; 2. History of vestibular disease or dizziness, digestive tract, central nervous system and other system diseases that may cause nausea and vomiting; 3. History of chronic pain requiring long-term use of analgesic or sedative drugs; 4.Combined with mental illness or cognitive impairment, unable to communicate well; 5. Subjects were expected to be transferred to ICU with an endotracheal tube after operation 6. Subjects who participated in other clinical trials within the past 4 weeks.

Design outcomes

Primary

MeasureTime frame
posteroperative nause and vomiting;CHRM3 rs2165870 Genotypes;

Secondary

MeasureTime frame
Posteroperative nause and vomiting;KCNB2 rs349358 Genotypes;COMT rs4680 Genotypes;ABCB1 rs1045642 Genotypes;Use of postoperative rescue antiemetics;Use of postoperative rescue analgesics;Use of postoperative patient-controlled intravenous analgesia ;Intraoperative consumption of sufentanil;NRS(Numerical Rating Scale) pain score;NRS(Numerical Rating Scale) pain score;NRS(Numerical Rating Scale) pain score;

Countries

China

Contacts

Public ContactHao Dandan

Beijing Friendship Hospital of Capital Medical University

hdd_anesthesia@163.com+86 151 2002 2447

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026